Search Orphan Drug Designations and Approvals
-
| Generic Name: | bispecific anti-GD2/anti-B7-H3 monoclonal antibody |
|---|---|
| Date Designated: | 02/26/2024 |
| Orphan Designation: | Treatment of Neuroblastoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Invenra Inc. 5510 Element Way Suite 400 Madison, Wisconsin 53719 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







